OBI Pharma Inc. announces the change of VP, Chief Medical Officer

To clarify the media report

Important resolutions of 2016 Annual General Shareholders' Meeting

The Re-election of Directors at 2016 Annual General Shareholders' Meeting

OBI Pharma 's 2016 Annual General Meeting has approved to release the newly elected Director from non-competition restriction

OBI Pharma, Inc. announces the re-appointment of Mr. Michael Chang as the Chairman of the Company.

The company was invited to participate in the overseas NDR (Non-Deal Roadshow) organized by Credit Suisse, and reported the study results presented in the 2016 ASCO.

OBI Pharma, Inc. will attend Cathay Securities' Conference on June 16th

To correct the company’s Investor Conference presentation content on June 5 2016

To clarify the media report